帕诺与IBS-C的早期和持续的症状缓解有关:一项后期分析
Brian E Lacy1, Andrea S Shin2, David J Cangemi3
1Division of Gastroenterology and Hepatology, Mayo Clinic, 4500 San Pablo Blvd, Jacksonville, FL 32224, USA.
Therapeutic advances in gastroenterology
|January 28, 2026
概括
与安慰剂相比,Tenapanor在IBS-C患者中更快地缓解便秘和腹部症状. 这项研究表明,tenapanor显著减少了排便和腹部不适的首次反应的时间.
科学领域:
- 胃肠病学 胃肠病学
- 临床药理学 临床药理学
- 医学统计 医学统计
背景情况:
- 便秘性刺激性肠综合征 (IBS-C) 显著影响患者的生活质量.
- 便秘和相关腹部症状的有效管理对于IBS-C患者至关重要.
研究的目的:
- 为了评估缓解便秘和腹部症状的时间,使用tenapanor.
- 为了比较tenapanor和安慰剂之间缓解症状的速度和一致性.
主要方法:
- 从三项随机的安慰剂对照试验中汇总数据的后期分析.
- 卡普兰-梅尔法用于估计反应的累积发病率.
- 考克斯的比例危险模型评估了影响响应时间的因素.
主要成果:
- 帕诺显示,第一次完全自发排便 (CSBM) 反应的中位时间为2周,与安慰剂4周相比.
- 腹部疼痛,不适和胀气缓解的中位时间为tenapanor的4-5周,与安慰剂的6-8周相比.
- 在12周内,巴诺对所有终点的每周反应率始终较高.
结论:
- 在IBS-C患者中,Tenapanor显著减少了肠道和腹部症状初始缓解的时间.
- 与安慰剂相比,Tenapanor在12周的治疗期间提供了更快,更一致的反应.
相关概念视频
Sustainable Development
15.1K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.1K
Drugs for Treatment of Diarrhea-Predominant IBS
699
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
699
Drugs for Treatment of Constipation-Predominant IBS
807
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
807
Design Example: Sustainability in Concrete Building
412
As the construction industry moves towards more eco-friendly practices, concrete's adaptability and its ability to incorporate sustainable features make it a key material in the drive towards greener building solutions.
There are multiple approaches to achieve sustainability in a commercial concrete building. For instance, construct a concrete parking area under the building, utilizing pervious concrete paver blocks in open areas to facilitate rainwater collection through an underground...
There are multiple approaches to achieve sustainability in a commercial concrete building. For instance, construct a concrete parking area under the building, utilizing pervious concrete paver blocks in open areas to facilitate rainwater collection through an underground...
412
Diabetes: Symptoms, Diagnosis, and Complications
2.3K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.3K
Negative and Cognitive Symptoms of Schizophrenia
534
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
534


